New cancer clinical trial: The Combination of Palbociclib With ddEC-P as Neoadjuvant Therapy in Triple Negative Breast Cancer

Published on: November 28, 2018 at 12:00PM
Conditions:   Breast Cancer;   Breast Diseases;   Breast Neoplasms
Interventions:   Drug: Palbociclib;   Drug: Placebo oral capsule;   Drug: Epirubicin;   Drug: Cyclophosphamide;   Drug: Paclitaxel
Sponsor:   Zhejiang Cancer Hospital
Not yet recruiting
https://ift.tt/2rchA7T